Literature DB >> 12630966

CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease.

M Sugimura, Y Kinouchi, S Takahashi, H Aihara, S Takagi, K Negoro, N Obana, Y Kojima, K Matsumoto, T Kikuchi, M Hiroki, S Oomori, T Shimosegawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12630966     DOI： 10.1046/j.0009-9163.2002.00174.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  14 in total

1.  DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.

Authors:  C L Noble; E R Nimmo; H Drummond; L Smith; I D R Arnott; J Satsangi
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

2.  Genotype and phenotype relation in inflammatory bowel disease.

Authors:  Yoshitaka Kinouchi; Kenichi Negoro; Sho Takagi; Seiichi Takahashi; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

3.  Distribution of common CARD15 variants in patients with sporadic Crohn's disease: cases from Turkey.

Authors:  F Aytül Uyar; Hülya Over-Hamzaoğlu; Filiz Türe; Ahmet Gül; Nurdan Tözün; Güher Saruhan-Direskeneli
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

4.  1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery.

Authors:  Ali Tüzün Ince; Ozden Hatirnaz; Oya Ovünç; Uğur Ozbek
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

5.  Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.

Authors:  Tsuyoshi Tanabe; Natsu Yamaguchi; Koichi Matsuda; Keiko Yamazaki; Satoshi Takahashi; Arinobu Tojo; Makoto Onizuka; Yoshinobu Eishi; Hideki Akiyama; Jun Ishikawa; Takehiko Mori; Masamichi Hara; Kazutoshi Koike; Keisei Kawa; Takakazu Kawase; Yasuo Morishima; Hiroki Amano; Mikiko Kobayashi-Miura; Takeyasu Kakamu; Yusuke Nakamura; Shigetaka Asano; Yasuyuki Fujita
Journal:  Int J Hematol       Date:  2011-05-15       Impact factor: 2.490

6.  Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.

Authors:  A S Peña
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

7.  The IL23 axis plays a key role in the pathogenesis of IBD.

Authors:  Dermot McGovern; Fiona Powrie
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

8.  Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients.

Authors:  Kumi Ishida; Takuya Inoue; Kaori Fujiwara; Taisuke Sakanaka; Ken Narabayashi; Sadaharu Nouda; Toshihiko Okada; Kazuki Kakimoto; Takanori Kuramoto; Ken Kawakami; Yosuke Abe; Toshihisa Takeuchi; Mitsuyuki Murano; Satoshi Tokioka; Eiji Umegaki; Kazuhide Higuchi
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

9.  Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Authors:  Luciana Rigoli; Claudio Romano; Rosario Alberto Caruso; Maria A Lo Presti; Chiara Di Bella; Vincenzo Procopio; Giuseppina Lo Giudice; Maria Amorini; Giuseppe Costantino; Maria D Sergi; Caterina Cuppari; Giovanna Elisa Calabro; Romina Gallizzi; Carmelo Damiano Salpietro; Walter Fries
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

Review 10.  The Innate Immune System: A Trigger for Many Chronic Inflammatory Intestinal Diseases.

Authors:  Nobuhiko Kamada; Gerhard Rogler
Journal:  Inflamm Intest Dis       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.